Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenshi Qinlian Tufuling Granules is a Traditional Chinese Medicine (TCM) herbal preparation presented in granule form. The name suggests a combination of several traditional Chinese herbs, primarily Tu Fu Ling (Smilax Glabrae Rhizoma), and likely Huang Qin (Scutellaria baicalensis) and Huang Lian (Coptis chinensis), with "Shenshi" potentially indicating a specific formulation or brand. In TCM, Tu Fu Ling is traditionally used to remove damp-heat, resolve toxicity, and ease joint discomfort. Huang Qin and Huang Lian are known for their heat-clearing and detoxifying properties. As a traditional herbal product, it is typically regarded as a dietary supplement and is not subject to the same regulatory approval processes as Western pharmaceutical drugs. Statements regarding its efficacy are generally based on traditional use and have not been evaluated by regulatory bodies like the US FDA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenshi Qinlian Tufuling Granules.